FDA officials approve first-of-a-kind pill called daraxonrasib to fight one of the deadliest types of cancer

The US Food and Drug Administration (FDA) approved a groundbreaking new drug for the most common form of pancreatic cancer, offering US patients a more effective treatment against one of the deadliest types of the disease.

FDA officials gave expedited approval to the first-of-a-kind pill, called daraxonrasib, that blocks a mutated protein that fuels tumor growth in more than 90% of pancreatic cancer cases. It’s an approach that has eluded drugmakers for decades.

Even products labeled ‘eco’, ‘green’ or ‘natural’ can contain dangerous compounds including Pfas

Common personal care products widely contain unlabeled toxic chemicals, results from a new peer-reviewed study suggest. The testing of more than 110 items ranging from shampoo to baby lotions found evidence of unlabeled toxic chemicals in about 85%.

Many contained multiple ingredients known to be carcinogens or health hazards, and even 26% of products labeled “eco”, “green” or “natural” contained at least one dangerous compound. The products averaged more than three times as many chemicals than were listed on labels.

A broad group of diseases in the agricultural powerhouse is top of mind for the midterm elections

In Iowa, one of the key battleground states in November’s midterm elections, just about every political candidate agrees on one thing: something must be done about the state’s rising rates of cancer.

The midwestern state has the second-highest rate of cancer nationwide and, together with Utah and West Virginia, is one of only three states where incidents of the disease are rising, according to cancer rate monitoring from the National Institute on Minority Health and Health Disparities.